PNC Financial Services Group’s First Tracks Biotherapeutics TRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAX
PNC Financial Services Group's TRAX Position: Q3 2026 in Review
PNC Financial Services Group reduced its First Tracks Biotherapeutics (TRAX) stake by 63% in Q3 2026, selling an estimated $5.66K and leaving 86 shares worth $3.05K. The position accounts for ﹤0.01% of the portfolio, ranked #4679.
PNC Financial Services Group first reported a position in TRAX in Q2 2026 and has held it in 2 quarters since. The position peaked at $4.65K in Q2 2026. 182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.
- PNC Financial Services Group held 86 shares of First Tracks Biotherapeutics worth $3.05K as of Q3 2026.
- PNC Financial Services Group sold 145 First Tracks Biotherapeutics shares in Q3 2026, an estimated $5.66K.
- First Tracks Biotherapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4679 holding.
- PNC Financial Services Group first reported a position in First Tracks Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
- PNC Financial Services Group's First Tracks Biotherapeutics position peaked at $4.65K in Q2 2026.
- 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.